The Division of Cardiology participates in and leads investigator-initiated studies, registry design and analysis and multicenter investigations, including both National Institutes of Health (NIH) studies and sponsored research studies. Through our close alignment with the Feinberg Cardiovascular Research Institute and the Department of Preventive Medicine, we have a robust translational investigational program that creates significant opportunities for population-based research, studies of well phenotyped cohorts and advanced epidemiology. The breadth of our focus spans prevention, treatment of acute coronary syndromes and complex arrhythmias, device therapies and management strategies for advanced heart disease.
T32 Training Grant
Funded by a NIH T32 Training Grant, the Northwestern Molecular and Translational Cardiovascular Training Program trains MD and PhD postdoctoral scientists in basic and translational research.
We are actively engaged in fundamental research addressing regenerative therapies; exploring large databases to obtain a better understanding of the risk for cardiovascular disease; identifying better IT strategies to generate alerts and early interventions for common diseases like heart failure and atrial fibrillation; developing new interventions for structural heart disease, including transcutaneous valve repair/replacements; advancing percutaneous procedures to treat hypertension; and exploring improved strategies to spur best quality and improved outcomes.
Learn more about the labs working in our division.
View ongoing clinical trials related to cardiology.
Read about the latest discoveries within our division.